Global Spinal Muscular Atrophy (SMA) Pipeline Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Spinal Muscular Atrophy (SMA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Spinal Muscular Atrophy (SMA) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Spinal Muscular Atrophy (SMA) Overview
  3. Therapeutics Development
  4. Pipeline Products for Spinal Muscular Atrophy (SMA) - Overview
  5. Pipeline Products for Spinal Muscular Atrophy (SMA) - Comparative Analysis
  6. Spinal Muscular Atrophy (SMA) - Therapeutics under Development by Companies
  7. Spinal Muscular Atrophy (SMA) - Therapeutics under Investigation by Universities/Institutes
  8. Spinal Muscular Atrophy (SMA) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Spinal Muscular Atrophy (SMA) - Products under Development by Companies
  13. Spinal Muscular Atrophy (SMA) - Products under Investigation by Universities/Institutes
  14. Spinal Muscular Atrophy (SMA) - Companies Involved in Therapeutics Development
  • Astellas Pharma Inc.
  • AveXis, Inc.
  • Bioblast Pharma Ltd.
  • Cytokinetics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genethon
  • Genzyme Corporation
  • GMP-Orphan SAS
  • Ionis Pharmaceuticals, Inc.
  • Longevity Biotech, Inc
  • Neurodyn Inc.
  • Neurotune AG
  • Novartis AG
  • Sarepta Therapeutics, Inc.
  • Voyager Therapeutics, Inc.
  • Vybion, Inc.
  • WAVE Life Sciences Ltd.

For more information visit http://www.researchandmarkets.com/research/s257rm/spinal_muscular

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716